Patent · US Active

Lentiviral vector capable of directly reflecting type I interferon response, preparation method thereof, and applications thereof

US11384366B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2017
Grant dateJul 12, 2022
Priority date
Expiry dateOct 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/04
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are a method for establishing a lentiviral vector system capable of directly reflecting type I interferon response, and applications thereof. The method for establishing the lentiviral vector system comprises: cutting a Gaussia luciferase at the position of amino acid 109, removing 16 amino acids from N-terminus, and cloning the two polypeptides into a lentiviral vector to form a lentiviral BiLC expression vector; and cloning a shuttle plasmid of pEntry-IRF3 or pEntry-IRF5 or pEntry-IRF7 by homologous recombination into the lentiviral BiLC expression vector, so as to construct a lentiviral vector IRF3-BiLC or IRF5-BiLC or IRF7-BiLC capable of directly reflecting type I interferon response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.